NFKB1 and escherichia coli infection: These findings suggest that MF63 and MK886 may suppress the secretion of pro-inflammatory cytokines and chemokines while promoting the release of anti-inflammatory mediators during E. coli infection, potentially by inhibiting E. coli-induced activation of the MAPK and NF-κB signaling pathways in BMDM.